share_log

MIRA Pharmaceuticals | 8-K: Current report

MIRA Pharmaceuticals | 8-K: Current report

MIRA Pharmaceuticals | 8-K:重大事件
美股SEC公告 ·  2024/11/21 21:22

牛牛AI助理已提取核心訊息

MIRA Pharmaceuticals announced that Michael Jerman has resigned from his position as Board member and Audit Committee Chair effective November 18, 2024, citing his desire to pursue other activities. The resignation was not due to any disagreements with the company.Matthew Pratt Whalen, CPA, has been appointed as the new Board member and Chairman of the Audit Committee. Whalen, 45, brings over two decades of experience in public accounting and corporate finance. He currently serves as CFO of Power Digital Marketing Inc. and as a director at Telmoir Pharmaceuticals. Previously, he held the CFO position at MRC Smart Technology Solutions, a Xerox subsidiary, from 2010 to 2021.
MIRA Pharmaceuticals announced that Michael Jerman has resigned from his position as Board member and Audit Committee Chair effective November 18, 2024, citing his desire to pursue other activities. The resignation was not due to any disagreements with the company.Matthew Pratt Whalen, CPA, has been appointed as the new Board member and Chairman of the Audit Committee. Whalen, 45, brings over two decades of experience in public accounting and corporate finance. He currently serves as CFO of Power Digital Marketing Inc. and as a director at Telmoir Pharmaceuticals. Previously, he held the CFO position at MRC Smart Technology Solutions, a Xerox subsidiary, from 2010 to 2021.
MIRA製藥公司宣佈,邁克爾·傑曼已於2024年11月18日辭去董事會成員及審計委員會主席職務,原因是他希望追求其他活動。辭職並非由於與公司存在任何分歧。馬修·普拉特·維倫,註冊會計師,被任命爲新的董事會成員和審計委員會主席。維倫,45歲,擁有超過20年的公共會計和企業金融經驗。他目前擔任Power Digital Marketing Inc.的財務長,以及Telmoir Pharmaceuticals的董事。此前,他在2010至2021年擔任施樂子公司MRC智能科技解決方案的財務長。
MIRA製藥公司宣佈,邁克爾·傑曼已於2024年11月18日辭去董事會成員及審計委員會主席職務,原因是他希望追求其他活動。辭職並非由於與公司存在任何分歧。馬修·普拉特·維倫,註冊會計師,被任命爲新的董事會成員和審計委員會主席。維倫,45歲,擁有超過20年的公共會計和企業金融經驗。他目前擔任Power Digital Marketing Inc.的財務長,以及Telmoir Pharmaceuticals的董事。此前,他在2010至2021年擔任施樂子公司MRC智能科技解決方案的財務長。

譯文內容由第三人軟體翻譯。


牛牛AI助手部分由第三方人工智慧模型基於資訊內容自動產生。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
評論 評論 · 瀏覽 364

熱點推薦

聲明

本頁的譯文內容由軟件翻譯。富途將竭力但卻不能保證翻譯內容之準確和可靠,亦不會承擔因任何不準確或遺漏而引起的任何損失或損害。